Project: Integrated Platform for de novo Design and Development of a Chimeric Enzyme for high-value chemicals

The CHImerASE project intends to develop a platform for the design of chimeric enzymes applied to new biotransformation steps. The team aims to deliver an efficient de novo designed enzyme to accomplish a high value industrial transformation that is currently only accessible via a laborious conventional chemical process. The consortium partners strongly believe that such innovative approach will represent a breakthrough in the biocatalysis field with a significant impact at industrial, economical and environmental levels. The multilateral consortium was set up based on the complementary expertise of three academic and non-profit research institutions, a world's leading chemical company which has a top market position in speciality chemicals manufacture and delivery, as well as unique know-how in biotech technology transfer and industrial process scale-up, and a SME biotech with consulting and manufacturing experience of engineered enzymes, resulting in a transnational cooperation between AT, Germany and Portugal.

Acronym CHImerASE
Website visit project website
Network ERA-IB-2
Call 4th ERA-IB Joint Call

Project partner

Number Name Role Country
ATn Centre of Industrial Biotechnology GmbH Austria
New University of Lisbon Coordinator Portugal
Heinrich Heine University of Düsseldorf Germany
Molekulare Biotechnologie Austria
BASF Group Germany